Carvedilol use and specific cancer risk in the population with hypertension

Affiliations

¹ Department of Medicine, Hualien-Armed Forces General Hospital, Hualien, Taiwan. Electronic address: farmer507@yahoo.com.tw.
² Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
³ Department of Internal Medicine, Mennorite Christian Hospital, Hualien, Taiwan.
⁴ Department of Medicine, Tri-Service General Hospital-SongShan Branch, National Defense Medical Center, Taipei, Taiwan.
⁵ Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Comment

Gen-Min Lin et al. Int J Cardiol. 2015.

. 2015 May 1:186:52-3.

doi: 10.1016/j.ijcard.2015.03.266. Epub 2015 Mar 20.

¹ Department of Medicine, Hualien-Armed Forces General Hospital, Hualien, Taiwan. Electronic address: farmer507@yahoo.com.tw.
² Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
³ Department of Internal Medicine, Mennorite Christian Hospital, Hualien, Taiwan.
⁴ Department of Medicine, Tri-Service General Hospital-SongShan Branch, National Defense Medical Center, Taipei, Taiwan.
⁵ Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

No abstract available

Keywords: Cancer risk; Carvedilol; Hypertension.

Comment in

Carvedilol use and specific cancer risk in the population with hypertension: Reply.
Lin CS, Hsu CW, Lin WS, Kao CH. Lin CS, et al. Int J Cardiol. 2015 Jul 1;190:159-60. doi: 10.1016/j.ijcard.2015.04.171. Epub 2015 Apr 22. Int J Cardiol. 2015. PMID: 25918071 No abstract available.

Carvedilol use is associated with reduced cancer risk: A nationwide population-based cohort study.
Lin CS, Lin WS, Lin CL, Kao CH. Lin CS, et al. Int J Cardiol. 2015 Apr 1;184:9-13. doi: 10.1016/j.ijcard.2015.02.015. Epub 2015 Feb 10. Int J Cardiol. 2015. PMID: 25705003